Top 5 Wine And Spirits VC Funds in Germany

Last updated: Jul 2024 A list of 5 VC funds that invest in Wine and spirits startups based in Germany. We rank investors based on the number of investments they made in Wine and spirits companies from Germany. We update this investor list every month.

Top 5 Wine And Spirits VC Funds in Germany

Investor	Wine And Spirits Germany investments
Loyal VC	2
Ace Ventures	1
Brandenburg Kapital	1
SquareOne	1
CNB Capital	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Loyal runs a global venture fund with quarterly redemptions and a proprietary gate-stage process, reducing investment bias and unlocking greater returns. Partnered with INSEAD, Founder Institute, and 500+ advisors, we are Loyal to the world with 250+ investments in 50+ countries.

Investment focus

Artificial Intelligence, Software, E-Commerce
Pre-Seed, Seed, Funding Round
United States, Canada, United Kingdom

Portfolio highlights

CurveBlock — CurveBlock aims to lead the real estate development industry in Financial Inclusion (The Shared Economy). CurveBlock sells digital shares in a real estate development fund that offers financial inclusion to ordinary members of society through the construction and sales of energy-independent real estate.
NIU NIU — NIU NIU is an e-Waste operating system that maximizes critical mineral extraction, while minimizing the environmental and social impact
The Leaf Protein Company — Unlocking Earth's most abundant source of proteins - green leaves.

Ace Ventures was designed to help new ideas, smart people and great companies to successfully enter the Internet business in Germany.

Investment focus

Apps, Electronics, Wine And Spirits
Series B, Seed, Series A
Germany, United States, Italy

Portfolio highlights

iMediSync — iMediSync provides automatic brain wave analysis and neuromodulation solutions.
Joy — Experience wedding planning the way it should be, from beautiful wedding websites and invitations, to registries and online RSVP.
Kither Biotech — Kither Biotech is a pharmaceutical product company that focuses its R&D activities on the development of new drugs. The R&D activities of the company mainly involve the development of new drugs to treat chronic inflammatory diseases.In recent years Kither has focused its first line of activities on the development of a small peptide(KIT2014) developed internally for the treatment of cystic fibrosis, a disease that predominantly affects the lungs and that currently has no cure. The KIT2014 peptide was assigned the Orphan Drug designation from the European Medicines Agency. The KIT2014 compound is currently undergoing the pre-clinical phase of clinical development.Kither’s product portfolio also includes a molecule (CL27), also developed internally, that is being developed for the treatment of Chronic Obstructive Pulmonary Diseases and Allergic Asthma. The company is about to start the pre-clinical phase of development of the CL27 molecule.

With a track record of over 20 years in venture capital and experience from more than 200 investments in numerous companies BFB Brandenburg Kapital GmbH (BFB) is the most active equity investor in Brandenburg. BFB invests in fast-growing technology-orientated companies throughout the whole life-cycle. Target sectors are ICT/Digital Economy,Life Science, MedTech, Proptech, Industrial Applications. BFB invests in companies based in or with facilities in Brandenburg. The current VC fund is financed by the European Regional Development Fund (ERDF) an Investitionsbank des Landes Brandenburg (ILB).

Investment focus

Software, Information Technology, Health Care
Seed, Series A, Funding Round
Germany, United Kingdom

Portfolio highlights

Dryad Networks — Overview of Dryad, providing ultra-early fire detection as well as forest growth and health monitoring.
Mateo — Mateo is the omni-channel customer experience powerhouse that empowers local brands and businesses to drive growth through a digital customer lifecycle management. From acquiring new leads, converting them into customers and extending those relationships - all in one platform.
Captain T Cell — Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients. The company identifies novel high-efficiency TCRs for the development of T cell immunotherapies. It focuses on CMC- and preclinical development for their lead candidates.

We invest in B2B tech entrepreneurs who are obsessed with solving complex problems in huge markets at pre-seed and seed stage

Investment focus

Software, SaaS, E-Commerce
Seed, Series A, Funding Round
Germany, United States, Poland

Portfolio highlights

Hero — Hero is a B2B payments and financing platform, offer direct online payment experience and receive your money immediately.
Otterspace — Otterspace takes care of DAOs.
Flinn Comply — We are driven to impact the health of millions of people around the globe by enabling medical companies to launch and operate products more efficiently. To make this vision come true, we established a customer-centric, experimentation-driven product development approach.

CNB Capital believes in the power of technology-driven entrepreneurship. We understand real innovation creates moat and defensibility. We provide long-term commitment, building an enduring partnership without the usual exit pressure.